Massive european study aims to redefine success in liver transplants
NCT ID NCT07585890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is collecting information from 10,000 liver transplant patients across Europe to create a new, up-to-date reference for what good outcomes look like when using machine perfusion (a technique that keeps donated livers healthier before transplant). The goal is to help doctors better understand which preservation methods work best for different patients and donor livers. Participants are adults receiving a liver transplant, and the study simply observes their recovery without testing any new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.O.U. Città della Salute e della Scienza
RECRUITINGTorino, Italy
Contact
-
University Medical Center Groningen
RECRUITINGGroningen, Provincie Groningen, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist
- Blood test and AI could spot liver cancer early, saving lives
- Could a simple nutritional plan boost survival after liver procedure?
- Which liver biopsy needle delivers the best tissue? a Head-to-Head comparison
- Blood type no barrier? study tests liver transplant success across ABO barriers